Maze Therapeutics (MAZE) Research & Development (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Research & Development data on file, last reported at $34.1 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 23.81% year-over-year to $34.1 million; the trailing twelve-month figure through Mar 2026 stood at $115.0 million (up 28.94% YoY), and the FY2025 full-year result was $108.4 million, up 29.88% from the prior year.
• Research & Development rose to $34.1 million in Q1 2026, from $27.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $34.1 million in Q1 2026 to a low of $19.5 million in Q2 2024.
• A 3-year average of $25.1 million and a median of $25.2 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 43.8% in 2025 and climbed 23.81% in 2026, its largest moves.
• Tracing MAZE's Research & Development over 3 years: stood at $22.2 million in 2024, then gained by 24.1% to $27.6 million in 2025, then rose by 23.86% to $34.1 million in 2026.
• Business Quant data shows MAZE's Research & Development at $34.1 million in Q1 2026, $27.6 million in Q4 2025, and $25.2 million in Q3 2025.